Literature DB >> 8027999

Tertiary structure of erabutoxin b in aqueous solution as elucidated by two-dimensional nuclear magnetic resonance.

H Hatanaka1, M Oka, D Kohda, S Tate, A Suda, N Tamiya, F Inagaki.   

Abstract

The three-dimensional structure of erabutoxin b, a short-chain neurotoxic peptide purified from the venom of the sea snake Laticauda semifasciata, was determined in aqueous solution by two-dimensional proton nuclear magnetic resonance and simulated annealing-based calculations. On the basis of 883 assigned nuclear Overhauser effect (NOE) connectivities, 676 final distance constraints were derived and used together with 38 torsion angle (phi, chi 1) constraints, four distance constraints derived from disulfide bridges and 30 distance constraints derived from hydrogen bonds. A total of 14 converged structures were obtained from 50 runs of calculations. The atomic root-mean-square difference about the mean coordinate positions (excluding the residues 18 to 22) is 0.60 A for backbone atoms (N, C alpha and C'). The protein consists of a core region from which three finger-like loops emerge outwards. It includes a short, two-stranded antiparallel beta-sheet of residues 2 to 5 and 13 to 16, a three-stranded antiparallel beta-sheet involving residues 23 to 30, 35 to 41 and 50 to 56, and four disulfide bridges in the core region. Comparison with two crystal structures of erabutoxin b at 1.4 A and 1.7 A resolution indicated that the solution and the crystal structures were very similar, but less defined regions were observed at the localized region of the tip of the central loop and the outside of the third loop in solution. Other short-chain alpha-neurotoxins showed structural characteristics similar to those of erabutoxin b.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027999     DOI: 10.1006/jmbi.1994.1429

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Structure and ligand recognition of the PB1 domain: a novel protein module binding to the PC motif.

Authors:  H Terasawa; Y Noda; T Ito; H Hatanaka; S Ichikawa; K Ogura; H Sumimoto; F Inagaki
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Cytotoxic potency of cardiotoxin from Naja sputatrix: development of a new cytolytic assay.

Authors:  Donghui Ma; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

3.  NMR structure of ubiquitin-like domain in PARKIN: gene product of familial Parkinson's disease.

Authors:  Mitsuru Tashiro; Seiji Okubo; Sakurako Shimotakahara; Hideki Hatanaka; Hideyo Yasuda; Masatsune Kainosho; Shigeyuki Yokoyama; Heisaburo Shindo
Journal:  J Biomol NMR       Date:  2003-02       Impact factor: 2.835

4.  Estimating the accuracy of protein structures using residual dipolar couplings.

Authors:  Katya Simon; Jun Xu; Chinpal Kim; Nikolai R Skrynnikov
Journal:  J Biomol NMR       Date:  2005-10       Impact factor: 2.835

5.  Solution structure of midkine, a new heparin-binding growth factor.

Authors:  W Iwasaki; K Nagata; H Hatanaka; T Inui; T Kimura; T Muramatsu; K Yoshida; M Tasumi; F Inagaki
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

6.  Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.

Authors:  K Ogura; K Nagata; H Hatanaka; H Habuchi; K Kimata; S Tate; M W Ravera; M Jaye; J Schlessinger; F Inagaki
Journal:  J Biomol NMR       Date:  1999-01       Impact factor: 2.835

Review 7.  Studies on sea snake venom.

Authors:  Nobuo Tamiya; Tatsuhiko Yagi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

8.  Solution structure of human insulin-like growth factor II; recognition sites for receptors and binding proteins.

Authors:  H Terasawa; D Kohda; H Hatanaka; K Nagata; N Higashihashi; H Fujiwara; K Sakano; F Inagaki
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

9.  Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4.

Authors:  K Nagata; D Kohda; H Hatanaka; S Ichikawa; S Matsuda; T Yamamoto; A Suzuki; F Inagaki
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.